F. Haab

1.8k total citations
107 papers, 1.3k citations indexed

About

F. Haab is a scholar working on Rheumatology, Urology and Surgery. According to data from OpenAlex, F. Haab has authored 107 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Rheumatology, 52 papers in Urology and 38 papers in Surgery. Recurrent topics in F. Haab's work include Pelvic floor disorders treatments (64 papers), Urinary Bladder and Prostate Research (47 papers) and Anorectal Disease Treatments and Outcomes (21 papers). F. Haab is often cited by papers focused on Pelvic floor disorders treatments (64 papers), Urinary Bladder and Prostate Research (47 papers) and Anorectal Disease Treatments and Outcomes (21 papers). F. Haab collaborates with scholars based in France, United Kingdom and United States. F. Haab's co-authors include Laurence Stewart, P. L. Dwyer, Christopher R. Chapple, V. Delmas, Philippe E. Zimmern, L. Cardozo, Arwin Ridder, Claus G. Roehrborn, David Castro‐Díaz and B Gattegno and has published in prestigious journals such as The Journal of Urology, European Urology and Urology.

In The Last Decade

F. Haab

103 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Haab France 17 949 862 415 407 223 107 1.3k
Pamela Ellsworth United States 20 507 0.5× 770 0.9× 451 1.1× 203 0.5× 170 0.8× 106 1.3k
Peter Ramsden United Kingdom 25 828 0.9× 1.2k 1.4× 300 0.7× 324 0.8× 484 2.2× 52 1.5k
Stephen A. Sihelnik United States 14 488 0.5× 869 1.0× 301 0.7× 190 0.5× 287 1.3× 17 1.1k
Hansjörg Melchior Germany 8 759 0.8× 633 0.7× 327 0.8× 284 0.7× 69 0.3× 12 1.0k
Prem Rashid Australia 17 644 0.7× 887 1.0× 169 0.4× 100 0.2× 703 3.2× 68 1.2k
Esther T. Kok Netherlands 17 306 0.3× 528 0.6× 294 0.7× 161 0.4× 272 1.2× 39 881
Richard C. Harkaway United States 20 314 0.3× 507 0.6× 228 0.5× 124 0.3× 493 2.2× 45 1.1k
Joseph Lee United States 9 2.3k 2.4× 1.5k 1.8× 1.2k 2.8× 785 1.9× 67 0.3× 19 2.5k
Karin Glavind Denmark 21 936 1.0× 515 0.6× 641 1.5× 344 0.8× 19 0.1× 71 1.2k
Michael E. Mayo United States 15 327 0.3× 509 0.6× 219 0.5× 97 0.2× 235 1.1× 35 819

Countries citing papers authored by F. Haab

Since Specialization
Citations

This map shows the geographic impact of F. Haab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Haab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Haab more than expected).

Fields of papers citing papers by F. Haab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Haab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Haab. The network helps show where F. Haab may publish in the future.

Co-authorship network of co-authors of F. Haab

This figure shows the co-authorship network connecting the top 25 collaborators of F. Haab. A scholar is included among the top collaborators of F. Haab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Haab. F. Haab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ballanger, P., G. Amarenco, Emmanuel Chartier‐Kastler, et al.. (2014). Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations. Progrès en Urologie. 24(11). e1–e7. 11 indexed citations
2.
Deffieux, X., B. Fatton, P. Denys, et al.. (2014). Injections intra-détrusoriennes de toxine botulinique pour l’hyperactivité vésicale idiopathique réfractaire de la femme. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 43(8). 572–580. 1 indexed citations
3.
Cornu, Jean‐Nicolas & F. Haab. (2013). Traitements pharmacologiques de l’hyperactivité vésicale idiopathique : revue de la littérature. Progrès en Urologie. 23(4). 227–236. 6 indexed citations
4.
5.
Haab, F., P. Van Kerrebroeck, Jiří Klečka, et al.. (2011). UP-02.014 Safety of Tamsulosin OCAS™ plus Solifenacin in Men with LUTS Associated with BPH in the SATURN Trial. Urology. 78(3). S264–S265. 1 indexed citations
6.
7.
Ragni, E., F. Haab, V. Delmas, & P. Costa. (2009). Physiopathologie des prolapsus génito-urinaires. Progrès en Urologie. 19(13). 926–931. 1 indexed citations
8.
Delmas, V., F. Haab, & P. Costa. (2009). Cystocèle : place des implants de renforcement par voie vaginale. Progrès en Urologie. 19(13). 1025–1030. 4 indexed citations
9.
Haab, F., P. Costa, & V. Delmas. (2009). Prise en charge des prolapsus génito-urinaires. Progrès en Urologie. 19(13). 1098–1102. 1 indexed citations
10.
Misraï, Vincent, et al.. (2009). La colporraphie traditionnelle a-t-elle encore une place dans le traitement de la colpocèle antérieure ?. Progrès en Urologie. 19(13). 1019–1024. 2 indexed citations
11.
Wagner, L., Francesc Macià, V. Delmas, F. Haab, & P. Costa. (2009). Traitement chirurgical du prolapsus par promontofixation par laparotomie. Progrès en Urologie. 19(13). 988–993. 2 indexed citations
12.
Wagg, Adrian, L. Cardozo, Christopher R. Chapple, et al.. (2008). Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?. International Journal of Clinical Practice. 62(10). 1588–1593. 6 indexed citations
13.
Kirby, Michael, Walter Artibani, L. Cardozo, et al.. (2006). Overactive bladder: the importance of new guidance. International Journal of Clinical Practice. 60(10). 1263–1271. 22 indexed citations
14.
Moudouni, S.M., et al.. (2006). Lymphoproliferative disorder presenting as a tumor of the renal allograft. International Urology and Nephrology. 38(3-4). 779–782. 2 indexed citations
15.
Schurch, Brigitte, M. de Sèze, P. Denys, et al.. (2005). Subgroup analysis to determine impact of patient demographics on urodynamic response to focal administration of botulinum toxin A.. Ghent University Academic Bibliography (Ghent University). 4 indexed citations
16.
Zinner, Norman R., et al.. (2005). Efficacy, tolerability and safety of darifenacin, an M3 selective receptor antagonist: an investigation of warning time in patients with OAB. International Journal of Clinical Practice. 60(1). 119–126. 37 indexed citations
17.
Tligui, M., et al.. (2004). Tumeur desmoïde du mesentère: Une cause exceptionnelle d\'obstruction urétérale. African Journal of Urology. 10(4). 282–284.
18.
Haab, F., L. Cardozo, Christopher R. Chapple, & Arwin Ridder. (2004). Long-Term Open-Label Solifenacin Treatment Associated with Persistence with Therapy in Patients with Overactive Bladder Syndrome. European Urology. 47(3). 376–384. 113 indexed citations
19.
Hampel, Christian, Walter Artibani, Montserrat Espuña Pons, et al.. (2004). Understanding the Burden of Stress Urinary Incontinence in Europe: A Qualitative Review of the Literature. European Urology. 46(1). 15–27. 103 indexed citations
20.
Haab, F., L Boccon-Gibod, V. Delmas, L. Boccon‐Gibod, & M Toublanc. (1994). Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer. British Journal of Urology. 74(5). 626–629. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela Ellsworth Breakdown of academic impact, for papers by Peter Ramsden Breakdown of academic impact, for papers by Stephen A. Sihelnik Breakdown of academic impact, for papers by Hansjörg Melchior Breakdown of academic impact, for papers by Prem Rashid Breakdown of academic impact, for papers by Esther T. Kok Breakdown of academic impact, for papers by Richard C. Harkaway Breakdown of academic impact, for papers by Joseph Lee Breakdown of academic impact, for papers by Karin Glavind Breakdown of academic impact, for papers by Michael E. Mayo
Rankless by CCL
2026